Clinical Trial Update: The Effects of Ranolazine on Exercise Capacity in Patients With Heart Failure With Preserved Ejection Fraction [NA]

View source ↗

Summary

A completed clinical trial evaluating the effects of ranolazine on exercise capacity in patients with heart failure with preserved ejection fraction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction

Drugs mentioned

• Ranolazine (ranolazine)

Snippet

Sponsor: University of California, San Diego | Conditions: Heart Failure With Preserved Ejection Fraction | NA | Status: COMPLETED | Results posted: 2020-01-18